Gastrointestinal Surgery held a 37.31% share of the endoluminal suturing devices market in 2025, reflecting its established role across a broad range of minimally invasive gastrointestinal procedures. Its leadership is maintained through the routine need for reliable tissue approximation and closure during complex endoscopic interventions, where procedural consistency and clinical familiarity support ongoing device use. The breadth of gastrointestinal surgery applications also gives this segment a wider procedural base than narrower use cases, helping it retain a leading share in the endoluminal suturing devices market.

Gastresophageal Reflux Surgery is emerging as the fastest-growing application in the endoluminal suturing devices market as treatment pathways increasingly favor less invasive approaches that can address reflux while reducing the burden associated with conventional surgery. Growth is being supported by rising procedural interest in endoscopic anti-reflux interventions, where suturing plays a practical role in reconstruction and durability of repair. Compared with broader gastrointestinal applications, this segment is gaining momentum because it aligns closely with the shift toward targeted, incision-sparing reflux management.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Within the endoluminal suturing devices market, hospitals accounted for the largest share in 2025 due to their concentration of advanced endoscopy infrastructure, multidisciplinary clinical teams, and higher capacity for managing complex cases. These settings remain the primary site for procedures that require specialized equipment, perioperative support, and established surgical backup, all of which reinforce hospital demand for endoluminal suturing devices. Their leading share is therefore tied to operational readiness and the ability to accommodate a broader mix of intervention complexity.

Ambulatory Surgical Centers represent the fastest-growing end-use segment in the endoluminal suturing devices market as procedural volumes increasingly shift toward outpatient environments that prioritize efficiency and shorter patient stays. Their momentum is strongest in cases where endoluminal suturing can be integrated into streamlined minimally invasive workflows without the resource intensity of a hospital setting. Relative to hospitals, ambulatory surgical centers are seeing wider adoption because they are well positioned for selected endoscopic procedures that benefit from faster turnover and lower site-of-care burden.